WIN 2022 Program

Saturday 29 October 2022

Sunday 30 October 2022

INTEGRATING GENOMICS AND TRANSCRIPTOMICS TO RESHAPE PRECISION ONCOLOGY: A WINNING STRATEGY
Saturday 29 October 2022
WELCOME AND OPENING REMARKS
	8:30 Welcome and Opening Remarks View the presentation	Richard L. Schilsky	Chairman WIN Consortium, Chevilly-Larue, France
		Josep Tabernero	Vice-Chairman WIN Consortium, Chevilly-Larue, France Vall d/Hebron Institute of Oncology (VHIO), Barcelona, Spain
	08:50 Opening Keynote Lecture Re-imagining the (r)evolution in the Precision Oncology paradigm: the future is now View the presentation	Vivek Subbiah	The University of Texas, MD Anderson Cancer Center, Houston, USA
SESSION 1 - BEYOND DNA TESTING: THE PLACE OF TRANSCRIPTOMICS IN PRECISION ONCOLOGY Chairs: Yves Lussier, Chairman, WIN Scientific Advisory Board, University of Utah School of Medicine, USA Ioana Berindean Neagoe, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj, Romania
	09:20 Keynote Lecture Rational development of targeted therapies to cure molecular subtypes of diffuse large B cell lymphoma (DLBCL) Watch the presentation	Louis M. Staudt	National Cancer Institute (NCI), Bethesda, USA
	09:50 Keynote Lecture Functional genomics to identify cancer vulnerabilities View the presentation	René Bernards	Netherlands Cancer Institute (NKI), Amsterdam, Netherlands
	10:20 Accelerating precision oncology using multi-omics and AI Watch the presentation	Olivier Elemento	Weill Cornell Medicine, New York, USA
10:50 Coffee break, networking
	11:15 Next generation transcriptomics-based Precision Oncology View the presentation	Eytan Ruppin	National Institute of Health (NIH), Bethesda, USA
	11:40 SIMS and Digital Display Precision Predictor algorithms View the presentation	Vladimir Lazar	WIN Consortium, Chevilly-Larue, France
	12:05 Modeling gene regulatory processes to understand cancer and identify therapies View the presentation	John Quackenbush	Harvard T.H. Chan School of Public Health, Boston, USA
12:35 Panel Discussion
13:00 Lunch, poster viewing and networking
SESSION 2 – INNOVATION IN CLINICAL TRIALS TO ENABLE FUTURE EFFICIENT TREATMENTS Chairs: Hikmat Abdel-Razeq, King Hussein Cancer Center, Jordan Cristiano de Pádua Souza, Fundação Pio XII – Hospital do Cancer de Barretos, Brazil
	14:30 Keynote opening Lecture Bringing single cell analyses to the clinics Watch the presentation	Andrea Califano	Columbia University Medical Center, New York, USA
	15:00 Keynote lecture Identifying new uses for approved, targeted drugs: Updates from the ASCO TAPUR study View the presentation	Richard L. Schilsky	WIN Consortium, Chevilly-Larue, France
	15:25 Genomic and transcriptomic signatures and innovation in CRC cancers View the presentation	Josep Tabernero	Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
	15:50 Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: comprehensive tumor genomic and transcriptomic analyses View the presentation	Jean-François Martini	Pfizer, Inc., San Diego, USA
	16:15 IO in combination: the SPRING trial tri-therapy approach View the presentation	Benjamin Solomon	Avera Cancer Institute, Sioux Falls, USA
16:40 Coffee break, networking
17:00 Sponsored Session: Satellite Symposium “Advancing Precision Oncology through Genomics”
18:00 Poster viewing
20:00 Symposium Dinner